The Scientist - Home

A pill is shown on a blue technical background. One half of the pill has a DNA helix on it, and the other half has a depiction of a computer chip, representing the role of artificial intelligence in drug development.
| 3 min read
2026 will be the year that artificial intelligence accelerates multiple aspects of the drug discovery and development pipeline, industry leaders predict.

Latest

The Scientist Placeholder Image

Researchers Decry Cutbacks In Government Grant Support

The Scientist Placeholder Image

Woman Scientist Victorious In Discrimination Case

The Scientist Placeholder Image

Environmental Fears Fuel Growth In Chemical Standards

The Scientist Placeholder Image

Space Science Is Expected To Gain Emphasis Under New NASA Head

The Scientist Placeholder Image

Notebook

The Scientist Placeholder Image

1992 Academy Awards: NAS Honors 13 Scientific Luminaries

The Scientist Placeholder Image

Maturing Biotech Firms Face New Challenges

The Scientist Placeholder Image

Reinvigorating The Mathematics Culture: The Problems Are Not Only Quantitative

The Scientist Placeholder Image

Biotechnology Regs Raise Ruckus

The Scientist Placeholder Image

U.S. Bioscience's Perilous Path From Class Act To Class Action

The Scientist Placeholder Image

People Briefs: Terril A. Nell

The Scientist Placeholder Image

People Briefs: Stanley Prusiner

February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies